April 20, 2017: Citron Research targets longs in Wayfair again, tweets: “Why is Wayfair the ONLY retailer who uses a manual process for accounting?” Citron notes earlier Andrew Left interview with TheStreet.com: https://www.thestreet.com/story/14093925/1/furniture-retailer-wayfair-another-madoff-andrew-left.html
December 16, 2016: Hearing takeover rumors circulating about Wayfair. The rumor is that Lowes is a possible buyer at a price of (Read More….)
April 10, 2017: Sell Qorvo for a 27% win and congrats if you made money on the trade.
February 1, 2017: Qorvo reports Q3 EPS of $1.35 versus the $1.25 estimate. Revenue also beat coming in at $826.3 million versus $820 million estimate.
But wait, there’s more!
The CEO said, “In the March quarter, (Read More….)
April 10, 2017: Sell Illumina for a 27% win and congrats if you made money on the trade.
January 31, 2017: Illumina beats on earnings and revenue. Illumina reports Q4 EPS of $0.85 versus the $0.81 estimate. Illumina also beat on revenue coming in at $619 million versus the $614 million estimate.
The CEO said, (Read More….)
March 9, 2017: Amicus Therapeutics has commenced the commercial launch of the precision medicine Galafold in Italy following the final publication of reimbursement guidelines by the Ministry of Health (Ministero della Salute). Galafold is now reimbursed in Italy as a therapy for long-term treatment of adults and adolescents aged 16 years and older with a (Read More….)
February 28, 2017: Valeant Pharmaceuticals reports Q4 EPS of $1.26 versus the $1.24 estimate. Revenue also beat coming in at $2.4 billion versus the $2.35 billion estimate.
CEO Joseph C. Papa said, “Over the past few months, our teams worked to stabilize and strengthen our corebusinesses, resolve legacy issues, improve operational processes, launch new products, (Read More….)
February 24, 2017: BJ’s Restaurants reports Q4 EPS of $0.55 versus the $0.40 estimate. Revenue also beat coming in at $265.6 million versus the $265 million estimate. Same store sales fell -2.2%.
Comments: “Despite a challenging industry-wide operating environment, we continued to increase our market share, as we outpaced the industry in terms of traffic (Read More….)
February 11, 2017: Selling ACADIA Pharmaceuticals Monday for about a 15.8% win. Congratulations if you were able to make money on the trade.
February 5, 2017: ACADIA Pharmaceuticals Inc reportedly receives takeover approach from AstraZeneca according to an article on StreetInsider. Source: http://www.streetinsider.com/Hot+M+and+A/ACADIA+%28ACAD%29+Said+to+Receive+Takeover+Offer+from+AstraZeneca+%28AZN%29+-+Source/12496195.html
Pfizer may also have interest in acquiring lead drug candidate Nuplazid but (Read More….)
February 8, 2017: The mainstream financial media reports that Grubhub Seamless Inc is expanding agreements with BWLD, Subway and PF Changs and adding agreements with Dennys, Red Robin, and Hooters.
January 19, 2017: Hearing takeover rumors circulating about GrubHub. The rumor is that Yelp is interested in acquiring the company. Could not confirm the (Read More….)
February 3, 2017: The Hartford Financial Services Group Inc reports Q4 EPS of $1.08 versus the $0.96 estimate. Revenue also beat coming in at $4.54 billion versus the $4.51 billion estimate.
The CEO said, “Commercial Lines had an excellent quarter, with a stable underlying combined ratio of 88.2, solid growth in new business, and (Read More….)
February 3, 2017: Raymond James and Baird crashed our long position in GoPro. Then Baird cut GoPro to an Underperform rating from Neutral and set a price target of $6. Let’s sell for a 1.17% gain. I’m not feeling it’s good to fight Raymond James and Baird over GoPro right now. GoPro’s stock did a (Read More….)
February 1, 2017: Hearing merger rumors circulating about Hertz Global. The rumor is that activist shareholder Carl Icahn could push for a merger with Avis. I could not confirm the source of the rumors.
December 14, 2016: MKM Partners reiterates a Buy rating on Hertz and sets a price target of $33.
December 13, (Read More….)
January 31, 2017: Hearing takeover rumors circulating about Avianca Holdings after reports in the mainstream financial press. The rumor is that Avianca Holdings’ largest shareholder Synergy Group was not happy with any of the three takeover offers received. Avianca Holdings and Synergy Group are looking for better offers.
December 17, 2016: I’m hearing takeover rumors (Read More….)
January 29, 2017: Hearing takeover rumors circulating about Lakeland Industries. The rumors are that a PE firm may make a bid at around $25 a share for Lakeland Industries. I actually think this rumor has some street cred. The current market cap of Lakeland Industries is $81.3 million which is really cheap considering Lakeland Industries (Read More….)
January 22, 2017: My research has caused me to be of the opinion that Kate Spade is one of the most promising takeover plays on Wall Street.
Back on December 28, 2016, rumors circulated that Kate Spade wanted to sell itself and had hired advisers to contact potential buyers. A day later, on December (Read More….)
January 20, 2017: Seeing heavy call activity on Hain Celestial. February calls are active again at more than 8x average daily volume.
December 12, 2016: Hain Celestial Group is coming off of a double bottom on takeover rumors that are circulating. The rumor is that GIS could be a possible suitor. Takeover rumors have been (Read More….)
January 6, 2017: Hearing takeover rumors circulating about Etsy. The rumor is that InterActive Corp is interested in acquiring the company for around $16 a share. The takeover rumors about Etsy started back on October 28, 2016, when former Yahoo CEO Ross Levinsohn said on CNBC that he thought Etsy could be a takeover target.
January 4, 2017: Seeing heavy call activity in Alexion Pharmaceuticals: 2,000 Aug $140 calls traded at $12.80. I wonder if the heavy call activity has anything to do with the takeover rumors that were circulating on December 20, 2016, about Alexion Pharmaceuticals?
December 22, 2016: Leerink defending Alexion Pharmaceuticals; Reiterates outperform rating and price target (Read More….)
January 3, 2017: Lots of merger and takeover rumors coming from the tobacco sector after the California Public Employees’ Retirement System (Calpers) voted on December 19, 2016, to sell off its remaining tobacco stocks worth about $550 million. Tobacco stocks did a big sell-off.
According to reports in the mainstream financial media, British American Tobacco (Read More….)
December 28, 2016: Hearing takeover rumors about biotechnology firm Intercept Pharmaceuticals. The rumor is that Novartis could be a potential acquirer. Can not find the source of the rumors. StreetInsider asked an Intercept Pharmaceuticals spokesperson about the rumor and the company said it will not comment on M&A speculation.
Intercept Pharmaceuticals Stock Chart
Intercept (Read More….)
December 26, 2016: Hearing takeover rumors circulating about OpGen. The rumors are coming from the fact that Merck Global Health Innovation Fund disclosed a huge 37.5% stake in OpGen according to a schedule 13D filing.
November 16, 2016: Rodman & Renshaw/H.C. Wainwright reiterates a Buy rating on OpGen but cuts their price target from $3.25 (Read More….)
December 21, 2016: Seeing heavy call activity in HD Supply, 1,955 February $45 calls trade at $1.25. This heavier call activity comes a day after reports circulating that HD Supply has hired an adviser to gauge takeover interest on pressure from Jana.
December 20, 2016: Industrial equipment wholesale company HD Supply has reportedly hired an (Read More….)
December 19, 2016: Sell Applied Materials for a 3.8% win in 9 trading days. Congratulations if you were able to make money on the trade. The sell comes as Goldman Sachs cuts AMAT to a Neutral rating from Buy, and sets a price target of $35. Try not to let a winning trade turn into (Read More….)
A weekly Saturday night financial show that attempts to predict market direction for the week ahead by looking at a variety of technical and fundamental indicators. This week’s show includes commentary on the Fed’s first and only rate hike in 2016, Eli Lilly’s long-acting Basal Insulin that’s now available in the US, takeover rumors circulating (Read More….)